Skip to content

Opening book details…

Can I read Co-delivery of microRNA-150 and quercetin by lipid nanoparticles (LNPs) for the targeted treatment of age-related macular degeneration (AMD) on EtoBox?

Co-delivery of microRNA-150 and quercetin by lipid nanoparticles (LNPs) for the targeted treatment of age-related macular degeneration (AMD) by Wei Li; Liang Chen; Zhongwei Gu; Zhoujiang Chen; Hong Li; Zhongxia Cheng; Hanmei Li; Liang Zou is a Biochemistry, Genetics and Molecular Biology article available to read on EtoBox.

What is Co-delivery of microRNA-150 and quercetin by lipid nanoparticles (LNPs) for the targeted treatment of age-related macular degeneration (AMD) about?

Age-related macular degeneration (AMD) is characterized by choroidal neovascularization (CNV), which leads to severe vision loss in middle-aged and elderly patients. Current treatments for CNV show weak, transient efficacy, and they can cause several adverse effects. A potential new treatment is to use microRNA-150 (mR150), which regulates physiological and pathological angiogenesis by modulating the expression of CXCR4 at the post-transcriptional level. Here, we developed solid lipid nanoparticles that we modified with an Asp-Gly-Arg peptide to target endothelial cells during abnormal angiogenesis, then we co-loaded them with mR150 and the anti-angiogenic drug quercetin. The resulting nanoparticles had an average size around 200 nm and showed strong ability to target the fundus and inhibit CNV for up to two weeks in a mouse model without causing retinal toxicity. They significantly enhanced the uptake of mR150 in vitro compared to free mR150 or nanoparticles without peptide. Our study suggests that co-administration of mR150 and quercetin has potential for treating age-related macular degeneration and that nanoparticles modified with Asp-Gly-Arg peptide are an effective platform f

Who reads Co-delivery of microRNA-150 and quercetin by lipid nanoparticles (LNPs) for the targeted treatment of age-related macular degeneration (AMD)?

It is typically read by researchers, students, and practitioners in Biochemistry, Genetics and Molecular Biology.

Author
Wei Li; Liang Chen; Zhongwei Gu; Zhoujiang Chen; Hong Li; Zhongxia Cheng; Hanmei Li; Liang Zou
Publisher
Elsevier BV
Published
2023
Language
EN
Field
Biochemistry, Genetics and Molecular Biology (Life Sciences)

More by Wei Li; Liang Chen; Zhongwei Gu; Zhoujiang Chen; Hong Li; Zhongxia Cheng; Hanmei Li; Liang Zou

Browse all works by Wei Li; Liang Chen; Zhongwei Gu; Zhoujiang Chen; Hong Li; Zhongxia Cheng; Hanmei Li; Liang Zou